This multidimensional investigation adds new insights to the understanding of similarities and differences between IDH-mt astrocytoma and grade 2 oligodendroglioma regarding molecular features, immune microenvironment, tumor purity, classification and prognosis. This evidence concerns the gene IDH2 and neoplasm.